Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913530
rs121913530
KRAS
0.880 GeneticVariation UNIPROT

dbSNP: rs121909071
rs121909071
SLC22A18
0.800 GeneticVariation UNIPROT Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. 25311215

2014
dbSNP: rs121909071
rs121909071
SLC22A18
0.800 GeneticVariation UNIPROT Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group. 24627688

2014
dbSNP: rs121909071
rs121909071
SLC22A18
0.800 GeneticVariation UNIPROT Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. 23562183

2013
dbSNP: rs121909071
rs121909071
SLC22A18
0.800 GeneticVariation UNIPROT Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group. 23667368

2013
dbSNP: rs121909071
rs121909071
SLC22A18
0.800 GeneticVariation UNIPROT Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. 24846033

2014
dbSNP: rs121913351
rs121913351
BRAF
0.800 GeneticVariation UNIPROT Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline. 25311215

2014
dbSNP: rs121913351
rs121913351
BRAF
0.800 GeneticVariation UNIPROT Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. 23562183

2013
dbSNP: rs121913351
rs121913351
BRAF
0.800 GeneticVariation UNIPROT Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group. 24627688

2014
dbSNP: rs121913351
rs121913351
BRAF
0.800 GeneticVariation UNIPROT Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group. 23667368

2013
dbSNP: rs121913351
rs121913351
BRAF
0.800 GeneticVariation UNIPROT Missense mutations of the BRAF gene in human lung adenocarcinoma. 12460919

2002
dbSNP: rs121913351
rs121913351
BRAF
0.800 GeneticVariation UNIPROT Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. 24846033

2014
dbSNP: rs121913469
rs121913469
ERBB2
0.710 GeneticVariation UNIPROT Lung cancer: intragenic ERBB2 kinase mutations in tumours. 15457249

2004
dbSNP: rs121913366
rs121913366
BRAF
0.700 GeneticVariation UNIPROT Missense mutations of the BRAF gene in human lung adenocarcinoma. 12460919

2002
dbSNP: rs1324578301
rs1324578301
NTRK2
0.700 GeneticVariation UNIPROT

dbSNP: rs1419255508
rs1419255508
MXRA5
0.700 GeneticVariation UNIPROT Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. 22696596

2012
dbSNP: rs17851045
rs17851045
KRAS
0.700 GeneticVariation UNIPROT

dbSNP: rs2071460
rs2071460
CSNK2A3 ; GALNT18
0.700 GeneticVariation UNIPROT

dbSNP: rs369042203
rs369042203
MXRA5
0.700 GeneticVariation UNIPROT Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. 22696596

2012
dbSNP: rs372594677
rs372594677
EPHA3
0.700 GeneticVariation UNIPROT

dbSNP: rs754393038
rs754393038
MXRA5
0.700 GeneticVariation UNIPROT Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. 22696596

2012
dbSNP: rs759222135
rs759222135
MXRA5
0.700 GeneticVariation UNIPROT Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. 22696596

2012
dbSNP: rs776590689
rs776590689
MXRA5
0.700 GeneticVariation UNIPROT Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. 22696596

2012
dbSNP: rs1051730
rs1051730
CHRNA3
T 0.800 GeneticVariation GWASCAT Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. 30104567

2018
dbSNP: rs1051730
rs1051730
CHRNA3
A 0.800 GeneticVariation GWASCAT Lung cancer susceptibility locus at 5p15.33. 18978790

2008